文献速递功能神经外科

完全内镜下微血管减压术治疗三叉神经痛:描述单中心经验的技术说明

Fully Endoscopic Microvascular Decompression for Trigeminal Neuralgia: Technical Note Describing a Single-Center Experience.
PubMed 文献 · World Neurosurg · 2022-07-08

该回顾性病例系列研究纳入了2016年9月至2020年2月单中心接受完全内镜下微血管减压术(e-MVD)的25例三叉神经痛患者,术前BNI评分均为V级;术后即刻全部疼痛消失(BNI I级),末次随访22例无痛、3例复发但药物可控(BNI III级),2例出现听力下降。作者认为e-MVD安全且可能有效,尚需更大前瞻性研究评估长期获益。

要点

  • 25例三叉神经痛患者接受e-MVD,术前BNI评分均为V级。
  • 术后即刻全部疼痛消失(BNI I级),末次随访22例无痛、3例复发(BNI III级)。
  • 并发症2例:均听力下降,其中1例术后7天短暂面肌无力并已恢复。

核心结论

  • 作者认为e-MVD是一种安全、可能有效的微血管减压术式,并为术者及手术团队提供更好的术野可视化。
  • 作者指出需要更大规模的前瞻性研究来评估e-MVD是否在长期临床结局上带来额外获益。

研究设计与样本

  • 单中心回顾性病例系列,纳入2016年9月至2020年2月期间接受e-MVD的三叉神经痛患者25例(男10例、女15例;平均[SD]年龄63[10.4]岁)。

主要发现

  • 所有患者术前BNI疼痛强度评分均为V级,左侧受累15例。
  • 术后即刻所有患者完全无痛(BNI评分I级)。
  • 末次随访时22例保持无痛,3例复发疼痛但药物可控(BNI评分III级)。
  • 2例出现并发症:均发生听力下降,其中1例术后7天出现短暂面肌无力,至末次随访已恢复。

关键数值与推荐

  • 采用5点Barro神经病学研究所(BNI)疼痛强度评分量化疼痛缓解。
  • 术前BNI评分均为V级;术后即刻均为I级;末次随访22例为I级、3例为III级。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Microscopic microvascular decompression (MVD) of the trigeminal nerve is the gold standard surgical treatment for medically refractory classical trigeminal neuralgia. Endoscopy has significantly advanced surgery and provides enhanced visualization of the cerebellopontine angle and its critical neurovascular structures. We present our initial experience of fully endoscopic microvascular decompression (e-MVD). METHODS: This retrospective case series investigated e-MVD performed from September 2016 to February 2020 at a single institution. Clinical data including presenting symptoms, medications, operative findings, postoperative complications, and outcomes were recorded. The 5-point Barrow Neurological Institute (BNI) pain intensity score was used to quantify patients' pain relief. RESULTS: During the study period, 25 patients with trigeminal neuralgia (10 males, 15 females; mean [SD] age = 63 [10.4] years) underwent e-MVD. All patients had a preoperative BNI score of V. The left side was affected in 15 patients. Complications occurred in 2 patients: both experienced hearing loss, and one experienced transient facial weakness 7 days after surgery. The facial weakness had resolved by the last follow-up. All patients were completely pain-free (BNI score I) immediately postoperatively. On latest follow-up, 22 patients have remained pain-free, and 3 patients have recurrent pain that is being controlled with medication (BNI score III). CONCLUSIONS: Our study demonstrated that e-MVD is a safe, possibly effective method of performing MVD with the added benefit of improved visualization of the operative field for the operating surgeon and the surgical team. Larger prospective studies are required to evaluate whether performing e-MVD confers any additional benefits in long-term clinical outcome of patients with trigeminal neuralgia.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Pak HL, Lambru G, Okasha M, et al. Fully Endoscopic Microvascular Decompression for Trigeminal Neuralgia: Technical Note Describing a Single-Center Experience. World Neurosurg. 2022. PMID: 35817347. doi:10.1016/j.wneu.2022.07.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。